Timothy Eberlein
Overview
Explore the profile of Timothy Eberlein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
153
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garsa A, Ferraro D, DeWees T, Deshields T, Margenthaler J, Cyr A, et al.
Int J Radiat Oncol Biol Phys
. 2013 Oct;
87(5):1043-50.
PMID: 24161428
Purpose: To prospectively examine quality of life (QOL) of patients with early stage breast cancer treated with accelerated partial breast irradiation (APBI) using high-dose-rate (HDR) interstitial brachytherapy. Methods And Materials:...
2.
Garsa A, Ferraro D, DeWees T, Margenthaler J, Naughton M, Aft R, et al.
Int J Radiat Oncol Biol Phys
. 2012 Oct;
85(4):965-70.
PMID: 23058060
Purpose: To prospectively evaluate cosmetic outcomes in women treated with accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy for early-stage breast cancer. Methods And Materials: Between 2004 and 2008, 151...
3.
Garsa A, Ferraro D, DeWees T, Margenthaler J, Naughton M, Aft R, et al.
Brachytherapy
. 2012 Jun;
12(2):99-106.
PMID: 22726878
Purpose: To report the incidence and potential predictors of fat necrosis in women with early stage breast cancer treated with adjuvant high-dose-rate (HDR) multicatheter interstitial brachytherapy. Methods And Materials: Between...
4.
Ferraro D, Garsa A, DeWees T, Margenthaler J, Naughton M, Aft R, et al.
Radiat Oncol
. 2012 Mar;
7:53.
PMID: 22458887
Background: Brachytherapy as adjuvant treatment for early-stage breast cancer has become widely available and offers patients an expedited treatment schedule. Given this, many women are electing to undergo brachytherapy in...
5.
Aft R, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, et al.
Lancet Oncol
. 2010 Apr;
11(5):421-8.
PMID: 20362507
Background: Treatment with bisphosphonates decreases bone loss and can increase disease-free survival in patients with breast cancer. The aim of our study was to assess the effect of zoledronic acid...